GlaxoSmithKline S.A.E (EGX:BIOC)

Market Cap	3.30B
Revenue (ttm)	2.99B
Net Income (ttm)	173.98M
Shares Out	83.51M
EPS (ttm)	2.08
PE Ratio	18.99
Forward PE	n/a
Dividend	0.75 (1.90%)
Ex-Dividend Date	Jul 18, 2024

Volume	20,047
Average Volume	51,433
Open	39.25
Previous Close	39.25
Day's Range	39.05 - 39.89
52-Week Range	24.70 - 47.30
Beta	0.95
RSI	59.04
Earnings Date	May 19, 2025

About GlaxoSmithKline S.A.E

GlaxoSmithKline S.A.E. engages in production of pharmaceutical chemicals. The company is involved in manufacture of general and specialty medicines, and vaccines. GlaxoSmithKline S.A.E. was founded in 1981 and is based in London, the United Kingdom. GlaxoSmithKline S.A.E operates as a subsidiary of Glaxo Group Limited.

• Industry: Pharmaceutical Preparations
• Founded: 1981
• Employees: 800
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: BIOC

Financial Performance

In 2024, GlaxoSmithKline S.A.E's revenue was 2.99 billion, an increase of 33.51% compared to the previous year's 2.24 billion. Earnings were 173.98 million, an increase of 187.78%.